| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/05/2003 | CN1395569A Oxazolidinone thioamides with piperazine amide substituents |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1395566A Corticotropin releasing factor antagonists |
| 02/05/2003 | CN1395490A Antigen-specific IgE antibody production inhibitors |
| 02/05/2003 | CN1395489A Physiologically balanced ionized acidic solution and methodology for use in wound healing |
| 02/05/2003 | CN1395485A Water soluble prodrugs of azole compounds |
| 02/05/2003 | CN1394871A Staphylococcus aureus virulence stimulating factor inhibiting peptide and its application |
| 02/05/2003 | CN1394867A Medicinal oligose and its preparation method and medicine composition containing said oligose |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/05/2003 | CN1394643A Medicine for curing subacute thyroiditis |
| 02/05/2003 | CN1394641A Medicine for external application for curing infantile pneumonia and preparing method thereof |
| 02/05/2003 | CN1394628A Pure Chinese medicine preparation for controlling virus |
| 02/05/2003 | CN1394625A Inflammation-relieving medicine |
| 02/05/2003 | CN1394608A Injection sterile powder containing erythromycin salt and M cholinergic receptor-blocking agent and its preparation method |
| 02/05/2003 | CN1394600A Peroral and pernasal administration compound and dry powder inhalant and its preparation method |
| 02/05/2003 | CN1394597A Process for preparing powder preparation |
| 02/05/2003 | CN1100876C DNA encoding human paplilloma virus type 18 |
| 02/05/2003 | CN1100763C Process for producing imidazole derivatives |
| 02/05/2003 | CN1100759C Xanthene and arcridine derivative and its use |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/05/2003 | CN1100564C Medicine for treating HIV infection, its composition and its use |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/05/2003 | CN1100539C Antifungal coposition |
| 02/04/2003 | WO2002014333A1 Phosphonocephem compound |
| 02/04/2003 | WO2002011734A1 Aqueous pharmaceutical compositions |
| 02/04/2003 | USRE37979 Pyrimidine derivatives and anti-viral agent containing the same as active ingredient thereof |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515135 Aminoaryl oxazolidinone N-oxides |
| 02/04/2003 | US6515119 Use of S-ydcB and B-ydcB, essential bacterial genes |
| 02/04/2003 | US6515116 Method of preparing form II crystals of clarithromycin |
| 02/04/2003 | US6515106 Modified T4 bacteriophage polypeptide with antibiotic, anti-viral, anti-cancer activity; has antibiotic activity without exhibiting muramidase (lysozyme) activity; use in veterinary/ human medicine, plant disease resistance; food preservation |
| 02/04/2003 | US6515028 Glucamine compounds for treating hepatitis virus infections |
| 02/04/2003 | US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents |
| 02/04/2003 | US6515019 Methods of providing symptomatic and prophylactic treatment for medical and neurological conditions |
| 02/04/2003 | US6515002 Compounds and compositions for treating C1s-mediated diseases and conditions |
| 02/04/2003 | US6514997 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/04/2003 | US6514986 Chiral fluoroquinolone arginine salt forms |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514980 Nucleoside analogs in combination therapy of herpes simplex infections |
| 02/04/2003 | US6514965 Substituted 1-benzazepines and derivatives thereof |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 02/04/2003 | US6514953 Calcium (3S) tetrahydro-3-furanyl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate |
| 02/04/2003 | US6514946 16-membered ring macrolide antibiotics and the treatment or prophylaxis of pasteurellosis of mammalian livestock or poultry using the same as an active ingredient |
| 02/04/2003 | US6514945 Azalide antibiotic compositions |
| 02/04/2003 | US6514943 Method and composition for preserving viruses |
| 02/04/2003 | US6514936 Antiviral methods using human rhinovirus receptor (ICAM-1) |
| 02/04/2003 | US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 02/04/2003 | US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines |
| 02/04/2003 | US6514745 Oncoprotein protein kinase |
| 02/04/2003 | US6514729 Recombinant interferon-beta muteins |
| 02/04/2003 | US6514726 Aspergillus fumigatus acetyl coenzyme-A carboxylase genes and polypeptides and uses thereof |
| 02/04/2003 | US6514692 Method for treatment of immunodeficiency virus infection |
| 02/04/2003 | US6514690 Immunoreactive antigens of Hepatitis E Virus |
| 02/04/2003 | US6514494 Bacterial strain, processed plant extracts, compostions containing same, processes for their preparation and their therapeutic and industrial applications |
| 02/04/2003 | US6514491 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/04/2003 | CA2421787A1 Aqueous pharmaceutical compositions |
| 02/04/2003 | CA2253490C Use of il-12 and ifn-.alpha. for the treatment of infectious diseases |
| 02/03/2003 | WO2002016312A2 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2418283A1 Novel compounds inhibiting factor xa activity |
| 01/31/2003 | WO2002007761A1 Inhibiting hepatitis c virus processing and replication |
| 01/31/2003 | CA2416603A1 Inhibiting hepatitis c virus processing and replication |
| 01/30/2003 | WO2003008595A2 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008576A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 01/30/2003 | WO2003008573A2 Silencing of gene expression by sirna |
| 01/30/2003 | WO2003008571A2 Chimeric chains that code for proteins that induce effects directed against viruses |
| 01/30/2003 | WO2003008564A2 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008533A2 Method for virus propagation |
| 01/30/2003 | WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008442A1 Novel acyl peptides with leishmanicidal activity |
| 01/30/2003 | WO2003008441A2 Moringa seed proteins |
| 01/30/2003 | WO2003008439A1 ANTIMICROBIAL COMPOSITIONS CONTAINING β-AMINO ACID OLIGOMERS |
| 01/30/2003 | WO2003008430A2 Porphyrin derivatives for photodynamic therapy |
| 01/30/2003 | WO2003008425A1 Novel bisphosphonate derivatives, their preparation methods and uses |
| 01/30/2003 | WO2003008410A2 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | WO2003008407A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 01/30/2003 | WO2003008395A1 Substituted isoxazoles and the use thereof as antibiotics |
| 01/30/2003 | WO2003008392A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 01/30/2003 | WO2003008389A1 Oxazolidinone derivatives as potential antimicrobials |
| 01/30/2003 | WO2003008379A1 Azasugar compounds |
| 01/30/2003 | WO2003008374A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | WO2003008373A1 Tyrosine hydrazides |
| 01/30/2003 | WO2003008365A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 01/30/2003 | WO2003007995A2 Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone |
| 01/30/2003 | WO2003007993A1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 01/30/2003 | WO2003007989A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/30/2003 | WO2003007986A2 Vaccine formulation potentiated by the combination of a dna and an antigen |
| 01/30/2003 | WO2003007985A2 Capsular polysaccharide solubilisation and combination vaccines |
| 01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | WO2003007946A1 Secondary 1,3-thiazole-5-yl sulfonamide derivatives and their use as antiviral agents |
| 01/30/2003 | WO2003007945A1 Viral polymerase inhibitors |
| 01/30/2003 | WO2003007935A2 Use of a class of antiviral compounds for production of an agent for the treatment or prevention of a viral infection in the respiratory tract |
| 01/30/2003 | WO2003007933A1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 01/30/2003 | WO2003007930A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/30/2003 | WO2003007883A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 01/30/2003 | WO2003007878A2 Antifungal agents of sordarin derivatives |